Leveraging Real-World Data for the Selection of Relevant Eligibility Criteria for the Implementation of Electronic Recruitment Support in Clinical Trials

被引:14
|
作者
Melzer, Georg [1 ]
Maiwald, Tim [2 ]
Prokosch, Hans-Ulrich [1 ]
Ganslandt, Thomas [1 ,3 ]
机构
[1] Friedrich Alexander Univ Erlangen Nurnberg, Chair Med Informat, Wetterkreuz 15, D-91058 Erlangen, Germany
[2] Friedrich Alexander Univ Erlangen Nurnberg, Dept Elect Engn, Inst Elect Engn, Erlangen, Germany
[3] Heidelberg Univ, Mannheim Univ Med, Dept Biomed Informat, Heinrich Lanz Ctr Digital Hlth, Mannheim, Germany
来源
APPLIED CLINICAL INFORMATICS | 2021年 / 12卷 / 01期
关键词
electronic health records and systems; data warehousing and data marts; secondary use; clinical trial; recruitment; PATIENT RECRUITMENT; MEDICAL INFORMATICS; SYSTEMS; ROUTINE; IMPACT; REPRESENTATION; QUALITY; CARE;
D O I
10.1055/s-0040-1721010
中图分类号
R-058 [];
学科分类号
摘要
Background Even though clinical trials are indispensable for medical research, they are frequently impaired by delayed or incomplete patient recruitment, resulting in cost overruns or aborted studies. Study protocols based on real-world data with precisely expressed eligibility criteria and realistic cohort estimations are crucial for successful study execution. The increasing availability of routine clinical data in electronic health records (EHRs) provides the opportunity to also support patient recruitment during the prescreening phase. While solutions for electronic recruitment support have been published, to our knowledge, no method for the prioritization of eligibility criteria in this context has been explored. Methods In the context of the Electronic Health Records for Clinical Research (EHR4CR) project, we examined the eligibility criteria of the KATHERINE trial. Criteria were extracted from the study protocol, deduplicated, and decomposed. A paper chart review and data warehouse query were executed to retrieve clinical data for the resulting set of simplified criteria separately from both sources. Criteria were scored according to disease specificity, data availability, and discriminatory power based on their content and the clinical dataset. Results The study protocol contained 35 eligibility criteria, which after simplification yielded 70 atomic criteria. For a cohort of 106 patients with breast cancer and neoadjuvant treatment, 47.9% of data elements were captured through paper chart review, with the data warehouse query yielding 26.9% of data elements. Score application resulted in a prioritized subset of 17 criteria, which yielded a sensitivity of 1.00 and specificity 0.57 on EHR data (paper charts, 1.00 and 0.80) compared with actual recruitment in the trial. Conclusion It is possible to prioritize clinical trial eligibility criteria based on real-world data to optimize prescreening of patients on a selected subset of relevant and available criteria and reduce implementation efforts for recruitment support. The performance could be further improved by increasing EHR data coverage.
引用
收藏
页码:17 / 26
页数:10
相关论文
共 50 条
  • [1] Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation Initiative
    Scott R. Evans
    Dianne Paraoan
    Jane Perlmutter
    Sudha R. Raman
    John J. Sheehan
    Zachary P. Hallinan
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 545 - 552
  • [2] Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation Initiative
    Evans, Scott R.
    Paraoan, Dianne
    Perlmutter, Jane
    Raman, Sudha R.
    Sheehan, John J.
    Hallinan, Zachary P.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (03) : 545 - 552
  • [3] Improving Diversity in Clinical Trials by Using Real-world Data to Define Eligibility Criteria
    Royce, Trevor J.
    Zhao, Yihua
    Ryals, Cleo A.
    JAMA ONCOLOGY, 2023, 9 (04) : 455 - 456
  • [4] Evaluating eligibility criteria of oncology trials using real-world data and AI
    Liu, Ruishan
    Rizzo, Shemra
    Whipple, Samuel
    Pal, Navdeep
    Pineda, Arturo Lopez
    Lu, Michael
    Arnieri, Brandon
    Lu, Ying
    Capra, William
    Copping, Ryan
    Zou, James
    NATURE, 2021, 592 (7855) : 629 - +
  • [5] Evaluating eligibility criteria of oncology trials using real-world data and AI
    Ruishan Liu
    Shemra Rizzo
    Samuel Whipple
    Navdeep Pal
    Arturo Lopez Pineda
    Michael Lu
    Brandon Arnieri
    Ying Lu
    William Capra
    Ryan Copping
    James Zou
    Nature, 2021, 592 : 629 - 633
  • [6] Leveraging Real-World Evidence to Enhance Clinical Trials
    Borkar, Durga S.
    Parke II, David W.
    Lee, Aaron Y.
    OPHTHALMOLOGY, 2024, 131 (07) : 756 - 758
  • [7] LEVERAGING REAL-WORLD DATA FOR TIME-TO-EVENT ENDPOINTS IN CLINICAL TRIALS
    Parashar, D.
    Almgren, P.
    Berglund, A.
    Guasconi, A.
    Smith, C.
    Torlinska, B.
    Wang, J.
    Wang, Q.
    VALUE IN HEALTH, 2022, 25 (01) : S256 - S256
  • [8] Missing data in the eligibility criteria of synthetic controls from real-world data
    Li, Liang
    Jemielita, Thomas
    Chen, Cong
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2025,
  • [9] Eligibility of real-world patients with metastatic breast cancer for clinical trials
    Batra, Atul
    Kong, Shiying
    Cheung, Winson Y.
    BREAST, 2020, 54 : 171 - 178
  • [10] Eligibility of real-world patients with metastatic breast cancer in clinical trials
    Batra, A.
    Kong, S.
    Rigo, R.
    Cheung, W.
    ANNALS OF ONCOLOGY, 2020, 31 : S70 - S70